Jiang Kewei*
The human gut is inhabited by trillions of microorganisms, collectively known as the gut microbiota. This complex ecosystem consists of bacteria, viruses, fungi, and other microorganisms. Emerging evidence suggests that the composition and functionality of the gut microbiota play a pivotal role in the development and progression of CVD. This article explores the mechanisms through which the gut microbiota influences CVD and discusses potential therapeutic implications. Chronic inflammation is a hallmark of many CVDs, including atherosclerosis. The gut microbiota exerts a profound influence on the host's immune system, modulating inflammatory responses. Dysbiosis, an imbalance in the gut microbiota composition, can promote a pro-inflammatory state through several mechanisms, Certain gut bacteria can produce LPS, a potent pro-inflammatory molecule. An overabundance of LPS in the gut can lead to increased systemic inflammation, contributing to CVD risk.
Teile diesen Artikel
English 
Spanish 
Chinese 
Russian 
French 
Japanese 
Portuguese 
Hindi 